Cue Biopharma, Inc. — DEFA14A Filings
12 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Cue Biopharma, Inc. (CUE), sorted by most recent first. Each row links to the full filing on EdgarLookup. Cue Biopharma, Inc. has filed 12 DEFA14A documents with the SEC since 2015. To view all SEC filings by Cue Biopharma, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B1
424B3
424B5
424B7
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
EFFECT
FWP
POS AM
POSASR
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001193125-26-129007 | Mar 27, 2026 | — |
| DEFA14A | DEFA14A | 0000950170-25-077389 | May 27, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-25-058677 | Apr 25, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-24-064528 | May 24, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-049044 | Apr 26, 2024 | — |
| DEFA14A | DEFA14A | 0001193125-23-126907 | Apr 28, 2023 | — |
| DEFA14A | DEFA14A | 0001193125-22-133541 | Apr 29, 2022 | — |
| DEFA14A | DEFA14A | 0001564590-21-020527 | Apr 26, 2021 | — |
| DEFA14A | DEFA14A | 0001193125-20-155724 | May 29, 2020 | — |
| DEFA14A | DEFA14A | 0001193125-19-175750 | Jun 18, 2019 | — |
| DEFA14A | DEFA14A | 0001193125-18-175561 | May 29, 2018 | — |
| DEFA14A | DEFA14A | 0001193125-18-143352 | Apr 30, 2018 | — |